Webinar of Interest! Patient Reported Outcomes (PRO) Symptom Data to Complement Traditional Exposure-Response (ER) Analysis for Dose optimization During Breast Cancer Drug Development

SPS Members are Invited to attend the following Webinar, hosted by the American Society for Clinical Pharmacology and Therapeutics (ASCPT)

Presented by the ASCPT Early Development & Drug Safety Community

ASCPT_webLogo.png
Title: Patient Reported Outcomes (PRO) Symptom Data to Complement Traditional Exposure-Response (ER) Analysis for Dose optimization During Breast Cancer Drug Development


Date and Time: Thursday, May 30, 2019, 1:00 pm ET

Speaker: Jeanne Fourie Zirkelbach, PhD

Moderator: Huiming Xia, PhD


Description: There is increasing interest in enhancing assessment of symptomatic adverse events (AEs) using patient self-reporting. In this presentation, exploratory efforts and results and future directions in term of how patient-reported outcome (PRO) - based Exposure Response analyses can complement conventional exposure-response (E-R) analysis will be discussed.


Learning Objective: Learn How Patient Report Outcome Endpoint Can Inform the Dose Selection and Dose Optimization.


Registration Required
https://attendee.gotowebinar.com/register/3232717416347253507

Recent Stories
SPS 2019-2021 Strategic Plan: Progress Report

You’re Invited! New Member & First-time Attendee Networking in Barcelona

You're Invited: Student and Jr. Investigator Speed Networking Event in Barcelona